Alan Wade

Summary

Country: UK

Publications

  1. ncbi Escitalopram in the long-term treatment of major depressive disorder
    Alan Wade
    CPS Research, Glasgow, United Kingdom
    Ann Clin Psychiatry 18:83-9. 2006
  2. ncbi The onset of effect for escitalopram and its relevance for the clinical management of depression
    Alan Wade
    CPS Clinical Research Centre, Glasgow, UK
    Curr Med Res Opin 22:2101-10. 2006
  3. ncbi A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder
    A Wade
    CPS Clinical Research Centre, Glasgow, United Kingdom
    Curr Med Res Opin 23:1605-14. 2007
  4. doi Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD)
    A G Wade
    CPS Clinical Research Centre, Glasgow, United Kingdom
    J Psychiatr Res 43:568-75. 2009
  5. ncbi A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care
    Alan Wade
    Community Pharmacology Services Ltd CPS, Clydebank, Glasgow, UK
    Int Clin Psychopharmacol 18:133-41. 2003
  6. ncbi Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder
    Ulla Lepola
    Kuopion Psykiatripalvelu OY Psychiatric Research, Clinic of Kuopio, Kuopio, Finland
    Int Clin Psychopharmacol 19:149-55. 2004
  7. ncbi Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial
    Stephen D Shafran
    Division of Infectious Diseases, Department of Medicine, 2E4 16 Walter C Mackenzie Health Sciences Centre, University of Alberta Hospital, 8440 112 Street, Edmonton, Alta, Canada T6G 2B7
    J Clin Virol 29:248-53. 2004

Collaborators

Detail Information

Publications7

  1. ncbi Escitalopram in the long-term treatment of major depressive disorder
    Alan Wade
    CPS Research, Glasgow, United Kingdom
    Ann Clin Psychiatry 18:83-9. 2006
    ..The long-term clinical tolerability and response to treatment are presented from a 12-month open-label study with a total exposure time to escitalopram of 486 patient years...
  2. ncbi The onset of effect for escitalopram and its relevance for the clinical management of depression
    Alan Wade
    CPS Clinical Research Centre, Glasgow, UK
    Curr Med Res Opin 22:2101-10. 2006
    ..To analyse the significance of 'onset of effect' on clinical outcome in the treatment of depression and the contribution of individual Montgomery-Asberg Depression Rating Scale (MADRS) items to improvements in the MADRS total score...
  3. ncbi A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder
    A Wade
    CPS Clinical Research Centre, Glasgow, United Kingdom
    Curr Med Res Opin 23:1605-14. 2007
    ..This study evaluated the efficacy and tolerability of escitalopram and duloxetine in the treatment of major depressive disorder (MDD)...
  4. doi Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD)
    A G Wade
    CPS Clinical Research Centre, Glasgow, United Kingdom
    J Psychiatr Res 43:568-75. 2009
    ..It is uncertain as to what short-term outcomes predict long-term treatment compliance and outcomes in patients with MDD...
  5. ncbi A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care
    Alan Wade
    Community Pharmacology Services Ltd CPS, Clydebank, Glasgow, UK
    Int Clin Psychopharmacol 18:133-41. 2003
    ....
  6. ncbi Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder
    Ulla Lepola
    Kuopion Psykiatripalvelu OY Psychiatric Research, Clinic of Kuopio, Kuopio, Finland
    Int Clin Psychopharmacol 19:149-55. 2004
    ..05, LOCF/OC). Escitalopram showed consistently superior efficacy compared to citalopram in the treatment of moderate to severe MDD on all efficacy parameters, and was similarly well tolerated...
  7. ncbi Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial
    Stephen D Shafran
    Division of Infectious Diseases, Department of Medicine, 2E4 16 Walter C Mackenzie Health Sciences Centre, University of Alberta Hospital, 8440 112 Street, Edmonton, Alta, Canada T6G 2B7
    J Clin Virol 29:248-53. 2004
    ....